Johnson & Johnson (JNJ) Stock Analysis

Johnson & Johnson (JNJ) Stock Analysis — AI Research | MarketCI

JNJ

Market Closed

Johnson & Johnson

NYSEHealthcare Drug Manufacturers - General

138.10K employees

CEO: Joaquin Duato

Founded: 1943

$228.39

+$0.00(+NaN%)

Market Cap

549.78B

Beta

0.26

52W Range

N/A

Dividend Yield

2.29%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

JNJ Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for JNJ built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Buy

Pass %

85.71%

Score

6/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$326.99

AI Price Target

Machine learning • Price prediction

$228.95

Market Sentiment

News & social media analysis

0.22

Value Investor Price

Classic value analysis

$39.99

Financial Health

Bankruptcy risk assessment

4.76

Quality Score

Financial strength rating

7.00

AI Investment Grade

Deep analysis of filings & news

78.00

Key Investment Highlights

Important factors affecting JNJ investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

78.57% Excellent

Conditions Met

33.00/42.00

Due Diligence Score

78.57%

Due Diligence Conditions

Investment analysis conditions and results


	Pass
	Fail
	Pass
	Pass
	Pass
	Pass

Showing 1 to 6 of 46 conditions